190 related articles for article (PubMed ID: 29412999)
1. Using TR-FRET to Investigate Protein-Protein Interactions: A Case Study of PXR-Coregulator Interaction.
Lin W; Chen T
Adv Protein Chem Struct Biol; 2018; 110():31-63. PubMed ID: 29412999
[TBL] [Abstract][Full Text] [Related]
2. Development of BODIPY FL vindoline as a novel and high-affinity pregnane X receptor fluorescent probe.
Lin W; Liu J; Jeffries C; Yang L; Lu Y; Lee RE; Chen T
Bioconjug Chem; 2014 Sep; 25(9):1664-77. PubMed ID: 25133934
[TBL] [Abstract][Full Text] [Related]
3. Identification of pregnane X receptor ligands using time-resolved fluorescence resonance energy transfer and quantitative high-throughput screening.
Shukla SJ; Nguyen DT; Macarthur R; Simeonov A; Frazee WJ; Hallis TM; Marks BD; Singh U; Eliason HC; Printen J; Austin CP; Inglese J; Auld DS
Assay Drug Dev Technol; 2009 Apr; 7(2):143-69. PubMed ID: 19505231
[TBL] [Abstract][Full Text] [Related]
4. A dual-acceptor time-resolved Föster resonance energy transfer assay for simultaneous determination of thyroid hormone regulation of corepressor and coactivator binding to the thyroid hormone receptor: Mimicking the cellular context of thyroid hormone action.
Jeyakumar M; Katzenellenbogen JA
Anal Biochem; 2009 Mar; 386(1):73-8. PubMed ID: 19111515
[TBL] [Abstract][Full Text] [Related]
5. Nelfinavir and Its Active Metabolite M8 Are Partial Agonists and Competitive Antagonists of the Human Pregnane X Receptor.
Burk O; Kronenberger T; Keminer O; Lee SML; Schiergens TS; Schwab M; Windshügel B
Mol Pharmacol; 2021 Mar; 99(3):184-196. PubMed ID: 33483427
[TBL] [Abstract][Full Text] [Related]
6. Regulation of PXR Function by Coactivator and Corepressor Proteins: Ligand Binding Is Just the Beginning.
Rigalli JP; Theile D; Nilles J; Weiss J
Cells; 2021 Nov; 10(11):. PubMed ID: 34831358
[TBL] [Abstract][Full Text] [Related]
7. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles.
Burk O; Kuzikov M; Kronenberger T; Jeske J; Keminer O; Thasler WE; Schwab M; Wrenger C; Windshügel B
Arch Toxicol; 2018 Apr; 92(4):1435-1451. PubMed ID: 29356861
[TBL] [Abstract][Full Text] [Related]
8. Mutation of a single amino acid of pregnane X receptor switches an antagonist to agonist by altering AF-2 helix positioning.
Huber AD; Wright WC; Lin W; Majumder K; Low JA; Wu J; Buchman CD; Pintel DJ; Chen T
Cell Mol Life Sci; 2021 Jan; 78(1):317-335. PubMed ID: 32232515
[TBL] [Abstract][Full Text] [Related]
9. Reverse yeast two-hybrid system to identify mammalian nuclear receptor residues that interact with ligands and/or antagonists.
Li H; Dou W; Padikkala E; Mani S
J Vis Exp; 2013 Nov; (81):e51085. PubMed ID: 24300333
[TBL] [Abstract][Full Text] [Related]
10. Helix 12 stabilization contributes to basal transcriptional activity of PXR.
Shizu R; Nishiguchi H; Tashiro S; Sato T; Sugawara A; Kanno Y; Hosaka T; Sasaki T; Yoshinari K
J Biol Chem; 2021 Sep; 297(3):100978. PubMed ID: 34284062
[TBL] [Abstract][Full Text] [Related]
11. Analysis of ligand-dependent recruitment of coactivator peptides to RXRbeta in a time-resolved fluorescence resonance energy transfer assay.
Stafslien DK; Vedvik KL; De Rosier T; Ozers MS
Mol Cell Endocrinol; 2007 Jan; 264(1-2):82-9. PubMed ID: 17184907
[TBL] [Abstract][Full Text] [Related]
12. Rifampicin-independent interactions between the pregnane X receptor ligand binding domain and peptide fragments of coactivator and corepressor proteins.
Navaratnarajah P; Steele BL; Redinbo MR; Thompson NL
Biochemistry; 2012 Jan; 51(1):19-31. PubMed ID: 22185585
[TBL] [Abstract][Full Text] [Related]
13. A vinblastine fluorescent probe for pregnane X receptor in a time-resolved fluorescence resonance energy transfer assay.
Lin W; Chen T
Anal Biochem; 2013 Dec; 443(2):252-60. PubMed ID: 24044991
[TBL] [Abstract][Full Text] [Related]
14. Indole microbial intestinal metabolites expand the repertoire of ligands and agonists of the human pregnane X receptor.
Illés P; Krasulová K; Vyhlídalová B; Poulíková K; Marcalíková A; Pečinková P; Sirotová N; Vrzal R; Mani S; Dvořák Z
Toxicol Lett; 2020 Nov; 334():87-93. PubMed ID: 33002526
[TBL] [Abstract][Full Text] [Related]
15. Chemical manipulation of an activation/inhibition switch in the nuclear receptor PXR.
Garcia-Maldonado E; Huber AD; Chai SC; Nithianantham S; Li Y; Wu J; Poudel S; Miller DJ; Seetharaman J; Chen T
Nat Commun; 2024 May; 15(1):4054. PubMed ID: 38744881
[TBL] [Abstract][Full Text] [Related]
16. In pursuit of synthetic modulators for the orphan retina-specific nuclear receptor NR2E3.
Qin Q; Knapinska A; Dobri N; Madoux F; Chase P; Hodder P; Petrukhin K
J Ocul Pharmacol Ther; 2013 Apr; 29(3):298-309. PubMed ID: 23098562
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of LanthaScreen™ TR-FRET-based nuclear receptor coactivator recruitment assay using PHERAstar, a multi-detection HTS microplate reader.
D'Souza PC; Ally N; Agarwal A; Rani P; Das M; Sarma D
Indian J Pharmacol; 2008 Mar; 40(2):89-90. PubMed ID: 21279174
[TBL] [Abstract][Full Text] [Related]
18. A homogeneous G protein-coupled receptor ligand binding assay based on time-resolved fluorescence resonance energy transfer.
Hu LA; Zhou T; Hamman BD; Liu Q
Assay Drug Dev Technol; 2008 Aug; 6(4):543-50. PubMed ID: 18699727
[TBL] [Abstract][Full Text] [Related]
19. Probing Ligand Structure-Activity Relationships in Pregnane X Receptor (PXR): Efavirenz and 8-Hydroxyefavirenz Exhibit Divergence in Activation.
Narayanan B; Lade JM; Heck CJS; Dietz KD; Wade H; Bumpus NN
ChemMedChem; 2018 Apr; 13(7):736-747. PubMed ID: 29430850
[TBL] [Abstract][Full Text] [Related]
20. Development of a coactivator displacement assay for the orphan receptor estrogen-related receptor-gamma using time-resolved fluorescence resonance energy transfer.
Gowda K; Marks BD; Zielinski TK; Ozers MS
Anal Biochem; 2006 Oct; 357(1):105-15. PubMed ID: 16889744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
